Myeloperoxidase Expression in Acute Myeloid Leukemia Helps Identifying Patients to Benefit from Transplant
Main Authors: | Kim, Yundeok, Yoon, Sulhee, Kim, Soo Jeong, Kim, Jin Seok, Cheong, Jun-Won, Min, Yoo Hong |
---|---|
Format: | Online |
Language: | English |
Published: |
Yonsei University College of Medicine
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343448/ |
Similar Items
-
Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
by: Kim, Jin Seok, et al.
Published: (2011) -
Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia
by: Park, Hyunsung, et al.
Published: (2017) -
An Unusual Case of Myeloperoxidase-Positive Acute Megakaryoblastic Leukemia
by: Lee, Hyeyoung, et al.
Published: (2015) -
Aurora A kinase expression is increased in leukemia stem cells, and a selective Aurora A kinase inhibitor enhances Ara-C-induced apoptosis in acute myeloid leukemia stem cells
by: Kim, Soo-Jeong, et al.
Published: (2012) -
Enhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance
by: CHEONG, JUNE-WON, et al.
Published: (2016)